Antibodies / Biosimilar Antibody

InVivoSIM Human, anti-Human IL-13 (Tralokinumab Biosimilar), Clone - Tralokinumab, IgG4, lambda, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £308.25 £231.25

SKU:: SIM0042
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Cell-based/Functional Assay, ELISA, Flow Cytometry
Clone:: Tralokinumab

View item

InVivoSIM Human, anti-Human IL-17A (Ixekizumab Biosimilar), Clone - Ixekizumab, IgG4, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £308.25 £231.25

SKU:: SIM0029
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Cell-based/Functional Assay, ELISA, Flow Cytometry, Immunofluorescence, Western Blot
Clone:: Ixekizumab

View item

InVivoSIM Human, anti-Human IL-17A (Secukinumab Biosimilar), Clone - Secukinumab, IgG1, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £267.00 £200.00

SKU:: SIM0013
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA, Flow Cytometry, Immunofluorescence, Immunohistochemistry
Clone:: Secukinumab

View item

InVivoSIM Human, anti-Human IL-1B Beta (Canakinumab Biosimilar), Clone - Canakinumab, IgG1, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £308.25 £231.25

SKU:: SIM0044
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Cell-based/Functional Assay, ELISA, Flow Cytometry
Clone:: Canakinumab

View item

InVivoSIM Human, anti-Human IL-23 (p19) (Guselkumab Biosimilar), Clone - Guselkumab, IgG1, lambda, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £308.25 £231.25

SKU:: SIM0025
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA, Western Blot
Clone:: Guselkumab

View item

InVivoSIM Human, anti-Human IL-4RA Alpha (CD124) (Dupilumab Biosimilar), Clone - Dupilumab, IgG4, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £308.25 £231.25

SKU:: SIM0023
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Cell-based/Functional Assay
Clone:: Dupilumab

View item

InVivoSIM Human, anti-Human IL-6 (Siltuximab Biosimilar), Clone - Siltuximab, IgG1, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £308.25 £231.25

SKU:: SIM0030
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Cell-based/Functional Assay, ELISA
Clone:: Siltuximab

View item

InVivoSIM Human, anti-Human IL-6R (Tocilizumab Biosimilar), Clone - Tocilizumab, IgG1, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £267.00 £200.00

SKU:: SIM0014
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Cell-based/Functional Assay, ELISA
Clone:: Tocilizumab

View item

InVivoSIM Human, anti-Human IgE (Omalizumab Biosimilar), Clone - Omalizumab, IgG1, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £267.00 £200.00

SKU:: SIM0016
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Block/Inhibit/Neutralise, ELISA, Flow Cytometry
Clone:: Omalizumab

View item

InVivoSIM Human, anti-Human LAG-3 (Relatlimab Biosimilar), Clone - Relatlimab, IgG4, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £267.00 £200.00

SKU:: SIM0015
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: ELISA
Clone:: Relatlimab

View item

InVivoSIM Human, anti-Human NGF (Tanezumab Biosimilar), Clone - Tanezumab, IgG2, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £267.00 £200.00

SKU:: SIM0017
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Block/Inhibit/Neutralise, ELISA
Clone:: Tanezumab

View item

InVivoSIM Human, anti-Human PD-1 (Cemiplimab Biosimilar), Clone - Cemiplimab, IgG4, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £308.25 £231.25

SKU:: SIM0037
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
Clone:: Cemiplimab

View item

InVivoSIM Human, anti-Human PD-1 (Nivolumab Biosimilar), Clone - Nivolumab, IgG4, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £267.00 £200.00

SKU:: SIM0003
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Block/Inhibit/Neutralise, Cell-based/Functional Assay, Flow Cytometry, Immunohistochemistry, Western Blot
Clone:: Nivolumab

View item

InVivoSIM Human, anti-Human PD-1 (Pembrolizumab Biosimilar), Clone - Pembrolizumab, IgG4, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £267.00 £200.00

SKU:: SIM0010
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Block/Inhibit/Neutralise, Cell-based/Functional Assay
Clone:: Pembrolizumab

View item

InVivoSIM Human, anti-Human PD-1 (Tislelizumab Biosimilar), Clone - Tislelizumab, IgG4, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £308.25 £231.25

SKU:: SIM0038
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
Clone:: Tislelizumab

View item

InVivoSIM Human, anti-Human PD-L1 (Atezolizumab Biosimilar), Clone - Atezolizumab, IgG1, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £267.00 £200.00

SKU:: SIM0009
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Block/Inhibit/Neutralise, Flow Cytometry, Western Blot
Clone:: Atezolizumab

View item

InVivoSIM Human, anti-Human PD-L1 (Avelumab Biosimilar), Clone - Avelumab, IgG1, lambda, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £308.25 £231.25

SKU:: SIM0021
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
Clone:: Avelumab

View item

InVivoSIM Human, anti-Human PD-L1 (Durvalumab Biosimilar), Clone - Durvalumab, IgG1, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £308.25 £231.25

SKU:: SIM0027
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Cell-based/Functional Assay, ELISA, Flow Cytometry, Western Blot
Clone:: Durvalumab

View item

InVivoSIM Human, anti-Human RANKL (CD254) (Denosumab Biosimilar), Clone - Denosumab, IgG1, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £308.25 £231.25

SKU:: SIM0028
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Cell-based/Functional Assay, Flow Cytometry
Clone:: Denosumab

View item

InVivoSIM Human, anti-Human SLAMF7 (Elotuzumab Biosimilar), Clone - Elotuzumab, IgG1, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

Was from £308.25 £231.25

SKU:: SIM0041
Size:: 1 mg, 100 mg, 25 mg, 5 mg, 50 mg
Suppl:: BioXCell
Appli:: Cell-based/Functional Assay, ELISA, Flow Cytometry, Immunoprecipitation, Western Blot
Clone:: Elotuzumab

View item

Basket

You currently have no items in your basket.

Antibodies

InVivoSIM Human, anti-Human IL-13 (Tralokinumab Biosimilar), Clone - Tralokinumab, IgG4, lambda, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human IL-17A (Ixekizumab Biosimilar), Clone - Ixekizumab, IgG4, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human IL-17A (Secukinumab Biosimilar), Clone - Secukinumab, IgG1, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human IL-1B Beta (Canakinumab Biosimilar), Clone - Canakinumab, IgG1, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human IL-23 (p19) (Guselkumab Biosimilar), Clone - Guselkumab, IgG1, lambda, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human IL-4RA Alpha (CD124) (Dupilumab Biosimilar), Clone - Dupilumab, IgG4, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human IL-6 (Siltuximab Biosimilar), Clone - Siltuximab, IgG1, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human IL-6R (Tocilizumab Biosimilar), Clone - Tocilizumab, IgG1, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human IgE (Omalizumab Biosimilar), Clone - Omalizumab, IgG1, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human LAG-3 (Relatlimab Biosimilar), Clone - Relatlimab, IgG4, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human NGF (Tanezumab Biosimilar), Clone - Tanezumab, IgG2, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human PD-1 (Cemiplimab Biosimilar), Clone - Cemiplimab, IgG4, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human PD-1 (Nivolumab Biosimilar), Clone - Nivolumab, IgG4, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human PD-1 (Pembrolizumab Biosimilar), Clone - Pembrolizumab, IgG4, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human PD-1 (Tislelizumab Biosimilar), Clone - Tislelizumab, IgG4, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human PD-L1 (Atezolizumab Biosimilar), Clone - Atezolizumab, IgG1, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human PD-L1 (Avelumab Biosimilar), Clone - Avelumab, IgG1, lambda, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human PD-L1 (Durvalumab Biosimilar), Clone - Durvalumab, IgG1, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human RANKL (CD254) (Denosumab Biosimilar), Clone - Denosumab, IgG1, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM

InVivoSIM Human, anti-Human SLAMF7 (Elotuzumab Biosimilar), Clone - Elotuzumab, IgG1, kappa, Endotoxin - <0.5EU/mg (<0.0005EU/ug), Determined by LAL gel clotting assay|InVivoSIM